Background and Aims
Most carcinoid tumors of the gastrointestinal tract are located in the small bowel (SB). Epidemiological studies of these tumors have been limited by small sample sizes. Our aim was to evaluate the epidemiology of SB carcinoids (SBCs) using a large database.
We queried a commercial database (Explorys), an aggregate of electronic health data from 26 US healthcare systems. We identified patients with SBCs between 2012 and 2017. We evaluated the epidemiology of SBC and identified possible risk factors.
Of the 35,798,290 individuals in the database between 2012 and 2017, we identified 3280 patients with SBCs, with a prevalence of 9.2/100,000. Prevalence was higher in men [odds ratio (OR) 1.23, 95% confidence interval (CI) 1.153–1.322, p < 0.0001], whites [OR 2.031, 95% CI 1.872–2.203, p < 0.0001], and elderly (aged > 65) [OR 4.856, 95% CI 4.533–5.203, p < 0.0001]. Patients with SBCs were more likely to have a history of smoking [OR 2.749, 95% CI 2.549–2.970, p < 0.0001], alcohol use [OR 2.031, 95% CI 1.864–2.21, p < 0.0001], obesity (BMI > 30) [OR 3.476, 95% CI 3.213–3.761, p < 0.0001], diabetes mellitus [OR 4.198, 95% CI 3.900–4.519, p < 0.0001], and a family history of cancer [OR 5.902, 95% CI 5.396–6.456, p < 0.0001].
This is one of the largest studies done on the prevalence of SBC. The prevalence of 9.2/100,000 individuals is higher than previously reported. Further genetic and environmental studies are needed to understand the potential mechanisms for the risk factors identified in this study.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Body mass index
Electronic health record
Failure to thrive
Health data gateway
Health Insurance Portability and Accountability Act
Inflammatory bowel disease
Institutional review board
Multiple endocrine neoplasia type 1
National Cancer Institute
Small bowel carcinoid
Surveillance, Epidemiology, and End Results
Systematized Nomenclature of Medicine-Clinical Terms
Lawrence B, Gustafsson BI, Chan A, et al. The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am. 2011;40:1–18.
Klimstra DS, Modlin IR, Coppola D, et al. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas. 2010;39:707–712.
KlÖppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci. 2004;1014:13–27.
Caplin ME, Buscombe JR, Hilson AJ, et al. Carcinoid tumour. The Lancet. 1998;352:799–805.
Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med. 1999;340:858–868.
von der Ohe MR, Michael C, Larry KK, et al. Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med. 1993;329:1073–1078.
Maton PN. The carcinoid syndrome. JAMA. 1988;260:1602–1605.
Pellikka PA, Tajik AJ, Khandheria BK, et al. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation. 1993;87:1188–1196.
Yao JC, Hassan M, Phan A, Dagohoy C, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–3072.
Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934–959.
Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79:813–829.
Godwin JD. Carcinoid tumors: an analysis of 2837 cases. Cancer. 1975;36:560–569.
Barclay THC, Schapira DV. Malignant tumors of the small intestine. Cancer. 1983;51:878–881.
Hemminki K, Li X. Incidence trends and risk factors of carcinoid tumors. Cancer. 2001;92:2204–2210.
Norheim I, Oberg K, Theodorsson-Norheim E, et al. Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival. Ann Surg. 1987;206:115.
Quaedvlieg PF, Visser O, Lamers CB, et al. Epidemiology and survival in patients with carcinoid disease in the Netherlands: an epidemiological study with 2391 patients. Ann Oncol. 2001;12:1295–1300.
Uhr JH, Shah J, Warner RR, et al. Racial disparities in clinical presentation and surgical outcomes in patients with small bowel carcinoid tumors. Am Surg. 2016;82:E89.
Bilimoria KY, Bentrem DJ, Wayne JD, et al. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009;249:63–71.
Kaerlev L, Teglbjaerg PS, Sabroe S, et al. The importance of smoking and medical history for development of small bowel carcinoid tumor: a European population-based case–control Study. Cancer Causes Control. 2002;13:27–34.
Hatzaras I, Palesty JA, Abir F, et al. Small-bowel tumors: epidemiologic and clinical characteristics of 1260 cases from the Connecticut tumor registry. Arch Surg. 2007;142:229–235.
Taal BG, Visser O. Epidemiology of neuroendocrine tumours. Neuroendocrinology. 2004;80:3–7.
Haselkorn T, Whittemore AS, Lilienfeld DE. Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Cancer Causes Control. 2005;16:781–787.
Neugut AI, Jacobson JS, Suh S, et al. The epidemiology of cancer of the small bowel. Cancer Epidemiol Prev Biomark. 1998;7:243–251.
Seydafkan S, Coppola D. Neuroendocrine neoplasms of the small intestine. In: Nasir A, Coppola D, eds. Neuroendocrine Tumors: Review of Pathology, Molecular and Therapeutic Advances. New York: Springer; 2016:273–288.
Mocellin S, Nitti D. Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531). Ann Oncol. 2013;24:3040–3044.
Maggard MA, O’Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004;240:117.
Naef M, Bühlmann M, Baer HU. Small bowel tumors: diagnosis, therapy and prognostic factors. Langenbeck’s Arch Surg. 1999;384:176–180.
Chow WH, Linet MS, McLaughlin JK, et al. Risk factors for small intestine cancer. Cancer Causes Control. 1993;4:163–169.
Wu AH, Yu MC, Mack TM. Smoking, alcohol use, dietary factors and risk of small intestinal adenocarcinoma. Int J Cancer. 1997;70:512–517.
Leoncini E, Carioli G, La Vecchia C, et al. Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis. Ann Oncol. 2015;27:68–81.
Cross AJ, Leitzmann MF, Subar AF, et al. Prospective study of meat and fat intake in relation to small intestinal cancer. Can Res. 2008;68:9274–9279.
Explorys Team. We unlock the power of BIG DATA to improve healthcare for everyone. Explorys 2015. https://www.explorys.com/about-us.html. Accessed August 25, 2016.
Vollset SE. Confidence intervals for a binomial proportion. Stat Med. 1993;12:809–824.
MedCalc Software Team. Odds ratio calculator. MedCalc 2017. https://www.medcalc.org/calc/odds_ratio.php. Accessed October 2, 2017.
Scosyrev E, Messing J, Noyes K, Veazie P, et al. Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: an overview. Urol Oncol. 2012;30:126–132.
Makridis C, Öberg K, Juhlin C, et al. Surgical treatment of mid-gut carcinoid tumors. World J Surg. 1990;14:377–383.
Kulke MH, Freed E, Chiang DY, et al. High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss. Genes Chromosom Cancer. 2008;47:591–603.
Hassan MM, Phan A, Li D, et al. Risk factors associated with neuroendocrine tumors: a US-based case–control study. Int J Cancer. 2008;123:867–873.
Teh BT, McArdle J, Chan SP, et al. Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia Type 1. Medicine. 1997;76:21–29.
Goudet P, Murat A, Cardot-Bauters C, et al. Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines). World J Surg. 2009;33:1197–1207.
Berna MJ, Annibale B, Marignani M, et al. Prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia Type 1 and Zollinger–Ellison syndrome: identification of risk factors. J Clin Endocrinol Metab. 2008;93:1582–1591.
Babovic-Vuksanovic D, Constantinou CL, Rubin J, et al. Familial occurrence of carcinoid tumors and association with other malignant neoplasms. Cancer Epidemiol Prev Biomark. 1999;8:715–719.
West NE, Wise PE, Herline AJ, et al. Carcinoid tumors are 15 times more common in patients with Crohn’s disease. Inflamm Bowel Dis. 2007;13:1129–1134.
Kaerlev L, Teglbjaerg PS, Sabroe S, et al. Occupational risk factors for small bowel carcinoid tumor: a European population-based case–control study. J Occup Environ Med. 2002;44:516–522.
Nadkarni PM, Darer JA. Migrating existing clinical content from ICD-9 to SNOMED. J Am Med Inform Assoc. 2010;17:602–607.
Mansoor E, Saleh MA, Cooper GS. Prevalence of eosinophilic gastroenteritis and colitis in a population-based study, from 2012 to 2017. Clin Gastroenterol Hepatol. 2017;15:1733–1741.
Kaelber DC, Foster W, Gilder J, et al. Patient characteristics associated with venous thromboembolic events: a cohort study using pooled electronic health record data. J Am Med Inform Assoc. 2012;19:965–972.
Chouhan V, Mansoor E, Parasa S, Cooper GS. Rates of prevalent colorectal cancer occurrence in persons 75 Years of age and older: a population-based national study. Dig Dis Sci. 2018;63:1–8. https://doi.org/10.1007/s10620-018-5073-9.
Al-Kindi SG, Oliveira GH. Prevalence of preexisting cardiovascular disease in patients with different types of cancer: the unmet need for onco-cardiology. Mayo Clin Proc. 2016;91:81–83.
Conflict of interest
The authors declare that they have no conflict of interest.
About this article
Cite this article
Abou Saleh, M., Mansoor, E., Anindo, M. et al. Prevalence of Small Intestine Carcinoid Tumors: A US Population-Based Study 2012–2017. Dig Dis Sci 64, 1328–1334 (2019). https://doi.org/10.1007/s10620-018-5402-z
- Risk factors